Results 11 to 20 of about 3,265,867 (293)
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention [PDF]
US Cardiology Review, 2020 Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual ...
Dimitrios Alexopoulos +2 more
doaj +2 more sources
Surgical tracheotomy performed with and without dual antiplatelet therapy
Open Medicine, 2014 Some patients who need dual antiplatelet therapy sometimes require tracheotomy. Aim of this study was to compare the rate of complications during and after surgical tracheotomy between patients requiring dual antiplatelet therapy and those without dual ...
Markota Andrej +2 more
doaj +2 more sources
Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation. [PDF]
PLoS ONE, 2016 Bleeding is a frequent complication in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO). An indication for dual antiplatelet therapy due to coronary stent implantation is present in a considerable number of these patients.
Dawid L Staudacher +5 more
doaj +2 more sources
Radiology Case ReportsDual antiplatelet therapy is commonly used to treat or prevent thromboembolic events in patients with deep vein thrombosis, pulmonary embolism, atrial fibrillation, in patients after coronary artery stenting, cerebral artery stenting or artificial heart ...
Nguyen The Anh +6 more
doaj +2 more sources
A novel method of thrombelastograph analysis aids assessment of antiplatelet therapy in percutaneous coronary intervention. [PDF]
, 2010 MD (Research)Background A near-patient test of responses to antiplatelet therapy would be of great value in percutaneous coronary intervention (PCI). However, at present, there are no widely accepted tests and varied definitions of “resistance”.
Hobson, Alex
core +4 more sources
, 2022 Antiplatelet agents have been utilized to enhance outcomes in patients with acute coronary syndrome for decades and are increasingly valued for their antithrombotic as well as anti-inflammatory characteristics. Dual antiplatelet therapy (DAPT) is a combination of aspirin and a P2Y12 inhibitor.
Edidiong Orok +2 more
openaire +1 more source
Российский кардиологический журнал, 2020 The feasibility of dual antiplatelet therapy as early as possible in patients with ST-segment elevation acute coronary syndrome, where percutaneous coronary intervention is recommended, has been proven: it improves treatment outcomes by reducing the risk
T. S. Golovina +2 more
doaj +1 more source
Український журнал серцево-судинної хірургії, 2023 The aim. To analyze changes in the activity of the platelet link of hemocoagulation in patients with chronic coronary syndrome before and after percutaneous coronary intervention (PCI) against the background of prior antiplatelet therapy.
Nataliia I. Kozachyshyn +2 more
doaj +1 more source
Single versus Dual Antiplatelet Therapy in Prevention of Early Stroke Recurrence after the First Acute Ischemic Stroke [PDF]
Zagazig University Medical JournalBackground: The dual antiplatelet therapy effectiveness compared with single antiplatelet therapy among acute non-cardioembolic ischemic stroke patients is still debated, especially as regards of functional outcomes, survival rates, and bleeding risks ...
El-Hady Abd El Gawwad +3 more
doaj +1 more source
Clinical presentations, antiplatelet strategies and prognosis of patients with stent thrombosis: an observational study of 140 patients. [PDF]
PLoS ONE, 2012 BACKGROUND: Until now there has been scarce evidence regarding an optimal antiplatelet strategy and clinical outcomes for patients who had suffered from stent thrombosis (ST).
Ya-Ling Han +12 more
doaj +1 more source